Table 2.
Response and relapse rates, stratified by CAR indication.
Refractory (N = 30) | 1st Relapse (N = 66) | ≥2nd Relapse (N = 87) | p-value | |
---|---|---|---|---|
Complete response rate | ||||
Morphology | 28 (93%) | 56 (85%) | 71 (82%) | 0.3061 |
MRD | ||||
Flow cytometry | 28 (93%) | 52 (79%) | 67 (77%) | 0.1324 |
Relapse rate∗ | ||||
Overall | 7 (25%) | 17 (30%) | 28 (39%) | 0.3490 |
CD19 status at relapse | ||||
CD19+ | 6 (86%) | 10 (59%) | 14 (50%) | |
CD19− | 1 (14%) | 7 (41%) | 14 (50%) | 0.2897 |
Relapse rate∗ amongst morphologic CR responders.